{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:22:20Z","timestamp":1791685340078,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Elena Pecci research project and the Fondazione Careggi Onlus"},{"DOI":"10.13039\/501100007747","name":"Red Espa\u00f1ola de Esclerosis M\u00faltiple","doi-asserted-by":"crossref","award":["RD16\/0015\/0001"],"award-info":[{"award-number":["RD16\/0015\/0001"]}],"id":[{"id":"10.13039\/501100007747","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Plan Estatal I+D+I , ISCIII-Subdirecci\u00f3n General de Evaluaci\u00f3n and Fondo Europeo de Desarrollo Regional","award":["Grant PI15\/00513"],"award-info":[{"award-number":["Grant PI15\/00513"]}]},{"name":"NIHR Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Soluble CD27 is a promising cerebrospinal fluid inflammatory biomarker in multiple sclerosis. In this study, we investigate relevant immune and neuro-pathological features of soluble CD27 in multiple sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Protein levels of soluble CD27 were correlated to inflammatory cell subpopulations and inflammatory cytokines and chemokines detected in cerebrospinal fluid of 137 patients with multiple sclerosis and 47 patients with inflammatory and non-inflammatory neurological disease from three independent cohorts. Production of soluble CD27 was investigated in cell cultures of activated T and B cells and CD27-knockout T cells. In a study including matched cerebrospinal fluid and post-mortem brain tissues of patients with multiple sclerosis and control cases, levels of soluble CD27 were correlated with perivascular and meningeal infiltrates and with neuropathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrate that soluble CD27 favours the differentiation of interferon-\u03b3-producing T cells and is released through a secretory mechanism activated by TCR engagement and regulated by neutral sphingomyelinase. We also show that the levels of soluble CD27 correlate with the representation of inflammatory T cell subsets in the CSF of patients with relapsing-remitting multiple sclerosis and with the magnitude of perivascular and meningeal CD27\u2009+\u2009CD4\u2009+\u2009and CD8\u2009+\u2009T cell infiltrates in post-mortem central nervous system tissue, defining a subgroup of patients with extensive active inflammatory lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Our results demonstrate that soluble CD27 is a biomarker of disease activity, potentially informative for personalized treatment and monitoring of treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-024-03077-9","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T12:02:16Z","timestamp":1712923336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Maria T.","family":"Cencioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Magliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keittisak","family":"Suwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fuentes-Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I.","family":"Fern\u00e1ndez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia Villarrubia","family":"Migall\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Costa-Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehiana","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Romozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Mazarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"3077_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378:169\u201380.","journal-title":"N Engl J Med"},{"key":"3077_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17:210\u20138.","journal-title":"Brain Pathol"},{"key":"3077_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI101335","volume":"21","author":"EA Kabat","year":"1942","unstructured":"Kabat EA, Moore DH, Landow H. An Electrophoretic Study of the Protein Components in Cerebrospinal Fluid and their relationship to the serum proteins. J Clin Invest. 1942;21:571\u20137.","journal-title":"J Clin Invest"},{"key":"3077_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2009.03.003","volume":"211","author":"LM Villar","year":"2009","unstructured":"Villar LM, Masterman T, Casanova B, Gomez-Rial J, Espino M, Sadaba MC, Gonzalez-Porque P, Coret F, Alvarez-Cermeno JC. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis. J Neuroimmunol. 2009;211:101\u20134.","journal-title":"J Neuroimmunol"},{"key":"3077_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ana.20890","volume":"59","author":"E Meinl","year":"2006","unstructured":"Meinl E, Krumbholz M, Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol. 2006;59:880\u201392.","journal-title":"Ann Neurol"},{"key":"3077_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, et al. Memory B cells activate Brain-Homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell. 2018;175:85\u2013e100123.","journal-title":"Cell"},{"key":"3077_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"IMS Genetics","year":"2011","unstructured":"Genetics IMS, Wellcome Trust Case Control C, Sawcer C, Hellenthal S, Pirinen G, Spencer M, Patsopoulos CC, Moutsianas NA, Dilthey L, Su A. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214\u20139.","journal-title":"Nature"},{"key":"3077_CR8","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1007\/s00415-020-10275-x","volume":"268","author":"B Arneth","year":"2021","unstructured":"Arneth B. Contributions of T cells in multiple sclerosis: what do we currently know? J Neurol. 2021;268:4587\u201393.","journal-title":"J Neurol"},{"key":"3077_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","volume":"13","author":"M Comabella","year":"2014","unstructured":"Comabella M, Montalban X. Body fluid biomarkers in multiple sclerosis. Lancet Neurol. 2014;13:113\u201326.","journal-title":"Lancet Neurol"},{"key":"3077_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2015.06.015","volume":"161","author":"WJ Housley","year":"2015","unstructured":"Housley WJ, Pitt D, Hafler DA. Biomarkers in multiple sclerosis. Clin Immunol. 2015;161:51\u20138.","journal-title":"Clin Immunol"},{"key":"3077_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/jnnp.66.6.791","volume":"66","author":"RQ Hintzen","year":"1999","unstructured":"Hintzen RQ, Paty D, Oger J. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1999;66:791\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3077_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2019.03.015","volume":"332","author":"A Feresiadou","year":"2019","unstructured":"Feresiadou A, Nilsson K, Ingelsson M, Press R, Kmezic I, Nygren I, Svenningsson A, Niemela V, Gordh T, Cunningham J, et al. Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease. J Neuroimmunol. 2019;332:31\u20136.","journal-title":"J Neuroimmunol"},{"key":"3077_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000489561","volume":"25","author":"B Liu","year":"2018","unstructured":"Liu B, Zhong X, Lu Z, Qiu W, Hu X, Wang H. Cerebrospinal fluid level of Soluble CD27 is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder. Neuroimmunomodulation. 2018;25:185\u201392.","journal-title":"Neuroimmunomodulation"},{"key":"3077_CR14","doi-asserted-by":"crossref","unstructured":"Mescheriakova JY, Runia TF, Jafari N, Siepman TA, Hintzen RQ. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome. JAMA Neurol 2017, 74:286\u2013292.","DOI":"10.1001\/jamaneurol.2016.4997"},{"key":"3077_CR15","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1177\/1352458518786655","volume":"24","author":"YYM Wong","year":"2018","unstructured":"Wong YYM, van der Vuurst RM, van Pelt ED, Ketelslegers IA, Melief MJ, Wierenga AF, Catsman-Berrevoets CE, Neuteboom RF, Hintzen RQ. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes. Mult Scler. 2018;24:1715\u201324.","journal-title":"Mult Scler"},{"key":"3077_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","volume":"78","author":"M Komori","year":"2015","unstructured":"Komori M, Blake A, Greenwood M, Lin YC, Kosa P, Ghazali D, Winokur P, Natrajan M, Wuest SC, Romm E, et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol. 2015;78:3\u201320.","journal-title":"Ann Neurol"},{"key":"3077_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/1352458518774880","volume":"25","author":"J Romme Christensen","year":"2019","unstructured":"Romme Christensen J, Komori M, von Essen MR, Ratzer R, Bornsen L, Bielekova B, Sellebjerg F. CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage. Mult Scler. 2019;25:937\u201346.","journal-title":"Mult Scler"},{"key":"3077_CR18","doi-asserted-by":"publisher","first-page":"578128","DOI":"10.1016\/j.jneuroim.2023.578128","volume":"381","author":"S El Mahdaoui","year":"2023","unstructured":"El Mahdaoui S, Husted SR, Hansen MB, Cobanovic S, Mahler MR, Buhelt S, von Essen MR, Sellebjerg F, Romme Christensen J. Cerebrospinal fluid soluble CD27 is associated with CD8(+) T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2023;381:578128.","journal-title":"J Neuroimmunol"},{"key":"3077_CR19","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1212\/NXI.0000000000000573","volume":"6","author":"A Klein","year":"2019","unstructured":"Klein A, Selter RC, Hapfelmeier A, Berthele A, Muller-Myhsok B, Pongratz V, Gasperi C, Zimmer C, Muhlau M, Hemmer B. CSF parameters associated with early MRI activity in patients with MS. Neurol Neuroimmunol Neuroinflamm. 2019;6:e573.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3077_CR20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4049\/jimmunol.182.1.718","volume":"182","author":"L Glouchkova","year":"2009","unstructured":"Glouchkova L, Ackermann B, Zibert A, Meisel R, Siepermann M, Janka-Schaub GE, Goebel U, Troeger A, Dilloo D. The CD70\/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia. J Immunol. 2009;182:718\u201325.","journal-title":"J Immunol"},{"key":"3077_CR21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.4049\/jimmunol.153.4.1421","volume":"153","author":"K Agematsu","year":"1994","unstructured":"Agematsu K, Kobata T, Sugita K, Freeman GJ, Beckmann MP, Schlossman SF, Morimoto C. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J Immunol. 1994;153:1421\u20139.","journal-title":"J Immunol"},{"key":"3077_CR22","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.4049\/jimmunol.1300022","volume":"190","author":"J Huang","year":"2013","unstructured":"Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, et al. Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol. 2013;190:6250\u20138.","journal-title":"J Immunol"},{"key":"3077_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/1352458520951536","volume":"27","author":"MT Cencioni","year":"2021","unstructured":"Cencioni MT, Ali R, Nicholas R, Muraro PA. Defective CD19\u2009+\u2009CD24(hi)CD38(hi) transitional B-cell function in patients with relapsing-remitting MS. Mult Scler. 2021;27:1187\u201397.","journal-title":"Mult Scler"},{"key":"3077_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41596-018-0069-7","volume":"14","author":"JF Hultquist","year":"2019","unstructured":"Hultquist JF, Hiatt J, Schumann K, McGregor MJ, Roth TL, Haas P, Doudna JA, Marson A, Krogan NJ. CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions. Nat Protoc. 2019;14:1\u201327.","journal-title":"Nat Protoc"},{"key":"3077_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, Yu Z, Yang J, Wang B, Sun H, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560:382\u20136.","journal-title":"Nature"},{"key":"3077_CR26","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Thery C. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968\u2013977.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3077_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.26448","volume":"92","author":"R Magliozzi","year":"2022","unstructured":"Magliozzi R, Fadda G, Brown RA, Bar-Or A, Howell OW, Hametner S, Marastoni D, Poli A, Nicholas R, Calabrese M, et al. Ependymal-in gradient of thalamic damage in progressive multiple sclerosis. Ann Neurol. 2022;92:670\u201385.","journal-title":"Ann Neurol"},{"key":"3077_CR28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/brain\/124.8.1635","volume":"124","author":"CJ De Groot","year":"2001","unstructured":"De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain. 2001;124:1635\u201345.","journal-title":"Brain"},{"key":"3077_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130:1089\u2013104.","journal-title":"Brain"},{"key":"3077_CR30","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"},{"key":"3077_CR31","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, Serafini B, Aloisi F, Roncaroli F, Magliozzi R, Reynolds R. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011;134:2755\u201371.","journal-title":"Brain"},{"key":"3077_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11222-016-9646-1","volume":"27","author":"B Gregorutti","year":"2017","unstructured":"Gregorutti B, Michel B, Saint-Pierre P. Correlation and variable importance in random forests. Stat Comput. 2017;27:659\u201378.","journal-title":"Stat Comput"},{"key":"3077_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/eji.200535744","volume":"36","author":"CR Ruprecht","year":"2006","unstructured":"Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006;36:810\u20136.","journal-title":"Eur J Immunol"},{"key":"3077_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20041674","volume":"201","author":"M Krumbholz","year":"2005","unstructured":"Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, Kalled SL, Hess DM, Serafini B, Aloisi F, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med. 2005;201:195\u2013200.","journal-title":"J Exp Med"},{"key":"3077_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004;14:164\u201374.","journal-title":"Brain Pathol"},{"key":"3077_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","volume":"173","author":"LG Ng","year":"2004","unstructured":"Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004;173:807\u201317.","journal-title":"J Immunol"},{"key":"3077_CR37","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3923\/pjbs.2008.1120.1125","volume":"11","author":"G Hassanshahi","year":"2008","unstructured":"Hassanshahi G, Jafarzadeh A, Esmaeilzadeh B, Arababadi MK, Yousefi H, Dickson AJ. Assessment of NK cells response to hepatocyte derived chemotactic agents. Pak J Biol Sci. 2008;11:1120\u20135.","journal-title":"Pak J Biol Sci"},{"key":"3077_CR38","doi-asserted-by":"crossref","unstructured":"Blandford SN, Fudge NJ, Moore CS. CXCL10 is Associated with increased Cerebrospinal Fluid Immune Cell Infiltration and Disease Duration in multiple sclerosis. Biomolecules 2023, 13.","DOI":"10.3390\/biom13081204"},{"key":"3077_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1468-1331.2001.00327.x","volume":"8","author":"TL Sorensen","year":"2001","unstructured":"Sorensen TL, Sellebjerg F, Jensen CV, Strieter RM, Ransohoff RM. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur J Neurol. 2001;8:665\u201372.","journal-title":"Eur J Neurol"},{"key":"3077_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","volume":"127","author":"TL Sorensen","year":"2002","unstructured":"Sorensen TL, Trebst C, Kivisakk P, Klaege KL, Majmudar A, Ravid R, Lassmann H, Olsen DB, Strieter RM, Ransohoff RM, Sellebjerg F. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol. 2002;127:59\u201368.","journal-title":"J Neuroimmunol"},{"key":"3077_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","volume":"26","author":"JE Simpson","year":"2000","unstructured":"Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2000;26:133\u201342.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3077_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archneurol.2010.99","volume":"67","author":"L Piccio","year":"2010","unstructured":"Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch Neurol. 2010;67:707\u201314.","journal-title":"Arch Neurol"},{"key":"3077_CR43","doi-asserted-by":"crossref","unstructured":"Irani DN. Regulated production of CXCL13 within the Central Nervous System. J Clin Cell Immunol 2016, 7.","DOI":"10.4172\/2155-9899.1000460"},{"key":"3077_CR44","doi-asserted-by":"crossref","unstructured":"Lundblad K, Zjukovskaja C, Larsson A, Cherif H, Kultima K, Burman J. CSF concentrations of CXCL13 and sCD27 before and after autologous hematopoietic stem cell transplantation for multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2023, 10.","DOI":"10.1212\/NXI.0000000000200135"},{"key":"3077_CR45","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbamem.2006.06.025","volume":"1758","author":"CJ Clarke","year":"2006","unstructured":"Clarke CJ, Hannun YA. Neutral sphingomyelinases and nSMase2: bridging the gaps. Biochim Biophys Acta. 2006;1758:1893\u2013901.","journal-title":"Biochim Biophys Acta"},{"key":"3077_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.111.181560","volume":"339","author":"WC Lin","year":"2011","unstructured":"Lin WC, Lin CF, Chen CL, Chen CW, Lin YS. Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury. J Pharmacol Exp Ther. 2011;339:45\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"3077_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","volume":"57","author":"AA Shamseddine","year":"2015","unstructured":"Shamseddine AA, Airola MV, Hannun YA. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul. 2015;57:24\u201341.","journal-title":"Adv Biol Regul"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T06:05:56Z","timestamp":1716444356000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03077-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3495160\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IRAS project ID 204872, REC reference 17\/L0\/0172 received approval from the Health Research Authority (HRA) and Health Care Research Wales (HCRW) ref 17\/LO\/0172\/ according to the Declaration of Helsinki.The study project of investigation FIS PI15\/00513 received approval from the ethics committee of University Hospital Ramon y Cajal according to the Declaration of Helsinki.All the human post-mortem tissues were collected with written informed consent forms via a prospective donor scheme with Ethical approval by the National Research Ethics Committee: IRAS project ID 246227, REC reference 18\/WA\/0238 according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"MTC, RM, MR, AM, IP, KS, JIFV, NVM, LCF, EM, LMV, RA, LFF, NM and RR declare no competing interests.RN declares to have attended paid advisory boards with Roche, Biogen, and Novartis; to have received grants from the UK MS Society; and to act as Vice-chair of the National Institute of Clinical and Health Excellence HTA committee C. PAM reports no competing interest, and discloses consulting to Magenta Therapeutics, Jasper Therapeutics and Cellerys, none related to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}